Wei‐Wen Lim
Impact in
-
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
-
- IL-33, ST2, and ILC Pathways
Papers in
-
- Cardiac Fibrosis and Remodeling 4
- Viral Infections and Immunology Research 3
- Cardiac electrophysiology and arrhythmias 3
- Cardiomyopathy and Myosin Studies 2
-
- IL-33, ST2, and ILC Pathways 5
- Immune Cell Function and Interaction 2
- Co-authors
- Stuart A. Cook (17 shared papers)Anissa A. Widjaja (14 shared papers)Sivakumar Viswanathan (9 shared papers)Benjamin Ng (9 shared papers)Sebastian Schäfer (10 shared papers)Han She Lim (1 shared paper)Say Leong Ong (1 shared paper)Alan D. Ziegler (1 shared paper)
- Journals
- International Journal of Molecular Sciences (5 papers)Nature Communications (3 papers)Scientific Reports (2 papers)Clinical and Experimental Pharmacology and Physiology (2 papers)iScience (1 paper)
- Partner nations
- SingaporeUnited KingdomAustralia
In The Last Decade
Wei‐Wen Lim
29 papers receiving 689 citations
Peers
Comparison fields: 5 of 108
- Cardiology and Cardiovascular Medicine 166
- Immunology 149
- Environmental Engineering 83
- Oncology 129
- Industrial and Manufacturing Engineering 38
Countries citing papers authored by Wei‐Wen Lim
This map shows the geographic impact of Wei‐Wen Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Wen Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Wen Lim more than expected).
Fields of papers citing papers by Wei‐Wen Lim
This network shows the impact of papers produced by Wei‐Wen Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Wen Lim. The network helps show where Wei‐Wen Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Wen Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 101 | |
| 2 | 2021 | 89 | |
| 3 | 2012 | 89 | |
| 4 | 2020 | 53 | |
| 5 | 2020 | 48 | |
| 6 | 2022 | 41 | |
| 7 | 2022 | 40 | |
| 8 | 2022 | 32 | |
| 9 | 2017 | 32 | |
| 10 | 2022 | 23 | |
| 11 | 2022 | 19 | |
| 12 | 2022 | 17 | |
| 13 | 2023 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 1996 | 13 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2009 | 9 | |
| 20 | 2023 | 8 |
About Wei‐Wen Lim
Wei‐Wen Lim is a scholar working on Cardiology and Cardiovascular Medicine, Immunology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 694 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Viral Infections and Immunology Research (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Cardiomyopathy and Myosin Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (166 citations), Immunology (149 citations), Environmental Engineering (83 citations), Oncology (129 citations) and Industrial and Manufacturing Engineering (38 citations). Wei‐Wen Lim has collaborated with scholars based in Singapore, United Kingdom and Australia. Frequent co-authors include Stuart A. Cook, Anissa A. Widjaja, Sivakumar Viswanathan, Benjamin Ng, Sebastian Schäfer, Han She Lim, Say Leong Ong, Alan D. Ziegler, Jiangyong Hu and Chen Xie. Their work appears in journals such as International Journal of Molecular Sciences, Nature Communications, Scientific Reports, Clinical and Experimental Pharmacology and Physiology and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.